阿帕替尼在恶性肿瘤治疗中的应用研究进展(4)
[10]Hu X，Cao J，Hu W，et al.Multicenter phase Ⅱ study of Apatinib in non-triple-negative metastatic breast cancer[J].BMC Cancer，2014，14：820.[11]Hu X，Zhang J，Xu B，et al.Multicenter phase Ⅱ study of Apatinib，a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer[J].Int J Cancer ......
您现在查看是摘要页，全文长 2719 字符。